Literature DB >> 24957331

Poststress block of kappa opioid receptors rescues long-term potentiation of inhibitory synapses and prevents reinstatement of cocaine seeking.

Abigail M Polter1, Rachel A Bishop1, Lisa A Briand2, Nicholas M Graziane1, R Christopher Pierce2, Julie A Kauer3.   

Abstract

BACKGROUND: Dopaminergic neurons in the ventral tegmental area of the brain are an important site of convergence of drugs and stress. We previously identified a form of long-term potentiation of gamma-aminobutyric acid (GABA)ergic synapses on these neurons (LTPGABA). Our studies have shown that exposure to acute stress blocks this LTP and that reversal of the block of LTPGABA is correlated with prevention of stress-induced reinstatement of cocaine-seeking behavior.
METHODS: Sprague-Dawley rats were subjected to cold-water swim stress. Midbrain slices were prepared following stress, and whole-cell patch clamp recordings of inhibitory postsynaptic currents were performed from ventral tegmental area dopamine neurons. Antagonists of glucocorticoid receptors and kappa opioid receptors (κORs) were administered at varying time points after stress. Additionally, the ability of a kappa antagonist administered following stress to block forced swim stress-induced reinstatement of cocaine self-administration was tested.
RESULTS: We found that an acute stressor blocks LTPGABA for 5 days after stress through a transient activation of glucocorticoid receptors and more lasting contribution of κORs. Even pharmacological block of κORs beginning 4 days after stress has occurred reversed the block of LTPGABA. Administration of a κORs antagonist following stress prevents reinstatement of cocaine-seeking behavior.
CONCLUSIONS: A brief stressor produces changes in the reward circuitry lasting several days. Our findings reveal roles for glucocorticoid receptors and κORs as mediators of the lasting effects of stress on synaptic plasticity. κORs antagonists reverse the neuroadaptations underlying stress-induced drug-seeking behavior and may be useful in the treatment of cocaine addiction.
Copyright © 2014 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glucocorticoid receptor; kappa opioid receptor; reinstatement; stress; synaptic plasticity; ventral tegmental area

Mesh:

Substances:

Year:  2014        PMID: 24957331      PMCID: PMC4240751          DOI: 10.1016/j.biopsych.2014.04.019

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  80 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

2.  Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats.

Authors:  Stephanie L Borgland; Robert C Malenka; Antonello Bonci
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

Review 3.  Effects of stress and aversion on dopamine neurons: implications for addiction.

Authors:  Mark A Ungless; Emanuela Argilli; Antonello Bonci
Journal:  Neurosci Biobehav Rev       Date:  2010-05-08       Impact factor: 8.989

4.  Glucocorticoids and behavioral effects of psychostimulants. II: cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels.

Authors:  V Deroche; M Marinelli; M Le Moal; P V Piazza
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

Review 5.  Role of kappa-opioid receptors in stress and anxiety-related behavior.

Authors:  Ashlee Van't Veer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

6.  Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats.

Authors:  N F Ramsey; J M Van Ree
Journal:  Brain Res       Date:  1993-04-16       Impact factor: 3.252

7.  Control of hormonal stress reactivity by the endogenous opioid system.

Authors:  Andras Bilkei-Gorzo; Ildiko Racz; Kerstin Michel; Daniela Mauer; Anne Zimmer; Dietrich Klingmüller; Andreas Zimmer
Journal:  Psychoneuroendocrinology       Date:  2008-02-15       Impact factor: 4.905

8.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

9.  Opioids block long-term potentiation of inhibitory synapses.

Authors:  Fereshteh S Nugent; Esther C Penick; Julie A Kauer
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

Review 10.  Reward and aversion in a heterogeneous midbrain dopamine system.

Authors:  Stephan Lammel; Byung Kook Lim; Robert C Malenka
Journal:  Neuropharmacology       Date:  2013-04-08       Impact factor: 5.250

View more
  30 in total

Review 1.  Long-Term Plasticity of Neurotransmitter Release: Emerging Mechanisms and Contributions to Brain Function and Disease.

Authors:  Hannah R Monday; Thomas J Younts; Pablo E Castillo
Journal:  Annu Rev Neurosci       Date:  2018-04-25       Impact factor: 12.449

Review 2.  Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms.

Authors:  Mitchell R Farrell; Hannah Schoch; Stephen V Mahler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-01-03       Impact factor: 5.067

Review 3.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

Review 4.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

Review 5.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

6.  Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice.

Authors:  Abdulrahman Almatroudi; Mehrnoosh Ostovar; Christopher P Bailey; Stephen M Husbands; Sarah J Bailey
Journal:  Br J Pharmacol       Date:  2017-11-06       Impact factor: 8.739

7.  Incisional Injury Modulates Morphine Reward and Morphine-Primed Reinstatement: A Role of Kappa Opioid Receptor Activation.

Authors:  Chinwe A Nwaneshiudu; Xiao-You Shi; J David Clark
Journal:  Anesth Analg       Date:  2020-01       Impact factor: 5.108

8.  Learned avoidance requires VTA KOR-mediated reductions in dopamine.

Authors:  Mykel A Robble; Mary E Bozsik; Daniel S Wheeler; Robert A Wheeler
Journal:  Neuropharmacology       Date:  2020-02-11       Impact factor: 5.250

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 10.  Inhibitory Plasticity of Mesocorticolimbic Circuits in Addiction and Mental Illness.

Authors:  Alexey Ostroumov; John A Dani
Journal:  Trends Neurosci       Date:  2018-08-24       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.